Acne Vulgaris: Chronic Inflammatory Disease: A Review

In contrast to how it is commonly understood, acne vulgaris (AV), which affects the pilosebaceous unit, which includes the hair follicle, hair shaft, and sebaceous gland, is a chronic inflammatory illness. It is one of the most prevalent dermatological conditions in the world. Disrupted sebaceous gland activity associated with hyperseborrhea (increased sebum production) and changes in sebum fatty acid composition, dysregulation of the hormone microenvironment, interaction with neuropeptides, follicular hyperkeratinization, induction of inflammation, and dysfunction of the innate and adaptive immune systems are just a few of the major mechanisms involved in the development of acne. Lesion counting and photographic techniques are used to grade acne lesions. The execution and comparability of randomised controlled clinical trials are hampered by the lack of agreement on the precise grading standards. Successful management of modifiable risk factors, such as underlying systemic disorders and lifestyle choices, is essential for acne prevention. Although there are many therapies, there is not enough information in the guidelines to provide recommendations that are supported by evidence. Additionally, the complicated combination medication regimens needed to address many parts of acne pathogenesis result in low adherence, which compromises the effectiveness of treatment. Scarring from acne is a typical side effect, and it lowers patients' quality of life. We will be better able to improve the outcomes for acne patients if new therapy options target the early processes involved in acne development as opposed to reducing the impacts of end products.